
USA - NASDAQ:ANPC - US03635R2067 - ADR
ChartMill assigns a Buy % Consensus number of 83% to ANPC. The Buy consensus is the weighted average rating of the current analysts ratings.
7 analysts have analysed ANPC and the average price target is 8.16 USD. This implies a price increase of 86.73% is expected in the next year compared to the current price of 4.37.
The consensus rating for ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.